📣 VC round data is live. Check it out!
- Public Comps
- Charles River Associates
Charles River Associates Valuation Multiples
Discover Charles River Associates' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like MLP, GlobalData, ASGN, SMS and more.
Charles River Associates Overview
About Charles River Associates
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.
Founded
1965
HQ

Employees
946
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialCharles River Associates Financials
Charles River Associates reported last 12-month revenue of $773M and EBITDA of $98M.
In the same LTM period, Charles River Associates generated $235M in gross profit, $98M in EBITDA, and $55M in net income.
Revenue (LTM)
Charles River Associates P&L
In the most recent fiscal year, Charles River Associates reported revenue of $801M and EBITDA of $111M.
Charles River Associates is profitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 14%, and net margin of 7%.
Financial data powered by Morningstar, Inc.
Charles River Associates Stock Performance
Charles River Associates has current market cap of $930M, and enterprise value of $1B.
Market Cap Evolution
Charles River Associates' stock price is $143.88.
Charles River Associates share price increased by 3.7% in the last 30 days, and decreased by 23.2% in the last year.
Charles River Associates has an EPS (earnings per share) of $8.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $930M | -1.9% | 3.7% | -11.1% | -23.2% | $8.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCharles River Associates Valuation Multiples
Charles River Associates trades at 1.5x EV/Revenue multiple, and 12.0x EV/EBITDA.
EV / Revenue (LTM)
Charles River Associates Financial Valuation Multiples
As of June 3, 2026, Charles River Associates has market cap of $930M and EV of $1B.
Charles River Associates has a P/E ratio of 17.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Charles River Associates Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Charles River Associates Margins & Growth Rates
Charles River Associates grew revenue by 5% but EBITDA decreased by 3% in the last fiscal year.
In the most recent fiscal year, Charles River Associates reported gross margin of 29%, EBITDA margin of 14%, and net margin of 7%.
Charles River Associates Margins
Charles River Associates Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Charles River Associates Operational KPIs
Charles River Associates' revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.2M for the same period.
Charles River Associates' Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Charles River Associates' Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Charles River Associates Competitors
Charles River Associates competitors include MLP, GlobalData, ASGN, SMS, RPMGlobal, MBB, Alexforbes, ICF International, Happiest Minds Technologies and Mastek.
Most Charles River Associates public comparables operate across Business Consulting.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.7x | 3.7x | 29.9x | 29.8x | |||
| 2.8x | 2.8x | 8.3x | 7.7x | |||
| - | 0.5x | - | 4.5x | |||
| 2.7x | 2.5x | 13.5x | 14.9x | |||
| - | 11.4x | - | 181.5x | |||
| 0.3x | 0.3x | 1.5x | 1.5x | |||
| 1.5x | - | 6.3x | - | |||
| 1.0x | 1.0x | 9.0x | 8.8x | |||
This data is available for Pro users. Sign up to see all Charles River Associates competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Charles River Associates
Charles River Associates has acquired 3 companies to date.
Last acquisition by Charles River Associates was on November 30th 2022. Charles River Associates acquired bioStrategies Group for undisclosed valuation.
Latest Acquisitions by Charles River Associates
| Description | bioStrategies Group is a consulting firm providing commercialization roadmaps and market access strategies to biopharmaceutical companies. It conducts product-level analyses using quantitative models to guide pricing, reimbursement, and launch planning across oncology, rare diseases, and immunology. Headquartered in Princeton, New Jersey, bioStrategies delivers board-level recommendations to support global market entry and revenue optimization. | Welch Consulting is a Chicago-based economics firm offering statistical analyses for employment discrimination litigation under Title VII and Equal Pay Act cases. Experts testify in federal courts using regression models on wage and promotion data for Fortune 500 defendants and plaintiffs. Retained in over 200 cases since 1992, it publishes peer-reviewed papers on labor economics and operates from offices in Illinois. | C1 Consulting is a Philadelphia-headquartered life sciences consultancy that develops commercialization strategies for pharmaceutical and biotech firms using analytics and market insights. The firm advises on pricing, access, and launch planning for therapies in oncology, immunology, and rare diseases. Founded in 2006, it has supported over 100 product launches including partnerships with Pfizer and Amgen across North America and Europe. |
| HQ Country | |||
| HQ City | Chicago, IL | Los Angeles, CA | Summit, NJ |
| Deal Date | 30 Nov 2022 | 1 Mar 2022 | 31 Jan 2017 |
| Valuation | undisclosed | $11M | $5M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Charles River Associates acquisitions and their M&A valuation multiples. Start Free Trial | |||
Investments by Charles River Associates
Charles River Associates has invested in 1 company to date.
Latest investment by Charles River Associates was on March 1st 2017. Charles River Associates invested in Freenome in their $65M Series A round (EV/Revenue multiple available to Pro users).
Latest Investments by Charles River Associates
| Description | Freenome is a South San Francisco-headquartered private biotechnology company specializing in early cancer detection via blood tests. It pioneers non-invasive screening using machine learning to analyze multiomics data for proactive management of cancers and other diseases. The approach aims to make advanced diagnostics accessible through innovative blood-based solutions. |
| HQ Country | |
| HQ City | San Francisco, CA |
| Deal Date | 1 Mar 2017 |
| Round | Series A |
| Raised | $65M |
| Investors | Agent Capital; Allen & Company; AME Cloud Ventures; Andreessen Horowitz; Asset Management Ventures (AMV); Charles River Associates; DCVC; Founders Fund; GV; Innovation Endeavors; Polaris Partners; S28 Capital |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Charles River Associates investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Charles River Associates
| When was Charles River Associates founded? | Charles River Associates was founded in 1965. |
| Where is Charles River Associates headquartered? | Charles River Associates is headquartered in United States. |
| How many employees does Charles River Associates have? | As of today, Charles River Associates has over 946 employees. |
| Who is the CEO of Charles River Associates? | Charles River Associates' CEO is Paul A. Maleh. |
| Is Charles River Associates publicly listed? | Yes, Charles River Associates is a public company listed on Nasdaq. |
| What is the stock symbol of Charles River Associates? | Charles River Associates trades under CRAI ticker. |
| When did Charles River Associates go public? | Charles River Associates went public in 1998. |
| Who are competitors of Charles River Associates? | Charles River Associates main competitors include MLP, GlobalData, ASGN, SMS, RPMGlobal, MBB, Alexforbes, ICF International, Happiest Minds Technologies, Mastek. |
| What is the current market cap of Charles River Associates? | Charles River Associates' current market cap is $930M. |
| What is the current revenue of Charles River Associates? | Charles River Associates' last 12 months revenue is $773M. |
| What is the current revenue growth of Charles River Associates? | Charles River Associates revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Charles River Associates? | Current revenue multiple of Charles River Associates is 1.5x. |
| What is the current EBITDA of Charles River Associates? | Charles River Associates' last 12 months EBITDA is $98M. |
| What is Charles River Associates' EBITDA margin? | Charles River Associates' last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Charles River Associates? | Current EBITDA multiple of Charles River Associates is 12.0x. |
| What is the current FCF of Charles River Associates? | Charles River Associates' last 12 months FCF is $40M. |
| What is Charles River Associates' FCF margin? | Charles River Associates' last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Charles River Associates? | Current FCF multiple of Charles River Associates is 29.4x. |
| How many companies Charles River Associates has acquired to date? | As of June 2026, Charles River Associates has acquired 3 companies. |
| What was the largest acquisition by Charles River Associates? | $11M acquisition of Welch Consulting on 1st March 2022 was the largest M&A Charles River Associates has done to date. |
| What companies Charles River Associates acquired? | Charles River Associates acquired Welch Consulting, C1 Consulting, and bioStrategies Group. |
| In how many companies Charles River Associates has invested to date? | As of June 2026, Charles River Associates has invested in 1 company. |
| What was the last Charles River Associates investment? | On 1st March 2017 Charles River Associates invested in Freenome, participating in a $65M Series A round, alongside Agent Capital, Allen & Company, AME Cloud Ventures, Andreessen Horowitz, Asset Management Ventures (AMV), DCVC, Founders Fund, GV, Innovation Endeavors, Polaris Partners, and 1 other investor. |
| In what companies Charles River Associates invested in? | Charles River Associates invested in Freenome. |
See public comps similar to Charles River Associates
Lists including Charles River Associates
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
